Medinova Diagnostic Services Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2018 Mar-2017 Mar-2016
Growth matrix (%)        
Revenue growth (14) 11.30 (3.40) 4.81
Op profit growth 105 444 (406) (99)
EBIT growth (125) (46) 36.60 (57)
Net profit growth (50) (74) (8.40) (47)
Profitability ratios (%)        
OPM 16 6.74 1.38 (0.40)
EBIT margin 4.27 (15) (31) (22)
Net profit margin (3.10) (5.20) (22) (24)
RoCE (10) 68.60 626 82.70
RoNW 0.60 1.18 4.78 6.15
RoA 1.78 5.98 110 22.10
Per share ratios ()        
EPS -- -- -- --
Dividend per share -- -- -- --
Cash EPS (1.20) (2.30) (4.40) (4)
Book value per share (9.20) (9.70) (9.60) (9.20)
Valuation ratios        
P/E -- -- -- --
P/CEPS (12) -- (7.90) (5.10)
P/B (1.50) -- (3.60) (2.20)
EV/EBIDTA 15.50 -- 174 188
Payout (%)        
Dividend payout -- -- -- --
Tax payout (17) (2.90) (2.90) (9.60)
Liquidity ratios        
Debtor days 13.70 10.90 18 26.70
Inventory days 4.41 4.21 6.09 7.69
Creditor days (273) (193) (198) (256)
Leverage ratios        
Interest coverage (0.50) 1.54 2.28 3.38
Net debt / equity (0.60) (0.70) (0.90) (1)
Net debt / op. profit 4.54 12.20 78 (250)
Cost breakup ()        
Material costs (15) (15) (14) (12)
Employee costs (26) (25) (28) (29)
Other costs (44) (52) (57) (59)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Revenue 7.45 8.67 7.79 8.06
yoy growth (%) (14) 11.30 (3.40) 4.81
Raw materials (1.10) (1.30) (1.10) (1)
As % of sales 14.60 15.50 14.50 12.20
Employee costs (1.90) (2.20) (2.10) (2.30)
As % of sales 25.80 25.30 27.60 28.70
Other costs (3.20) (4.60) (4.40) (4.80)
As % of sales 43.60 52.50 56.60 59.50
Operating profit 1.20 0.58 0.11 --
OPM 16 6.74 1.38 (0.40)
Depreciation (1) (1.90) (2.70) (1.90)
Interest expense (0.60) (0.80) (1.10) (0.50)
Other income 0.07 -- 0.14 0.19
Profit before tax (0.30) (2.10) (3.50) (2.30)
Taxes 0.05 0.06 0.10 0.22
Tax rate (17) (2.90) (2.90) (9.60)
Minorities and other -- -- -- 0.17
Adj. profit (0.20) (2.10) (3.40) (1.90)
Exceptional items -- 1.63 1.63 --
Net profit (0.20) (0.50) (1.70) (1.90)
yoy growth (%) (50) (74) (8.40) (47)
NPM (3.10) (5.20) (22) (24)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Profit before tax (0.30) (2.10) (3.50) (2.30)
Depreciation (1) (1.90) (2.70) (1.90)
Tax paid 0.05 0.06 0.10 0.22
Working capital 5.69 2.82 -- (2.80)
Other operating items -- -- -- --
Operating cashflow 4.51 (1.10) (6) (6.80)
Capital expenditure 0.85 (3.30) -- 3.26
Free cash flow 5.36 (4.40) (6) (3.50)
Equity raised (35) (37) (37) (36)
Investments -- -- -- --
Debt financing/disposal 6.61 6.08 6.12 8.34
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash (23) (35) (37) (32)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 9.96 9.96 9.96 9.96
Preference capital -- -- -- --
Reserves (19) (19) (20) (20)
Net worth (9.20) (8.90) (9.70) (9.60)
Minority interest
Debt 5.64 6.43 7.26 8.45
Deferred tax liabilities (net) -- -- -- --
Total liabilities (3.70) (2.70) (2.70) (1.10)
Fixed assets 2.40 3.34 4.48 6.89
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) 0.26 0.21 0.15 0.06
Net working capital (6.60) (6.30) (7.40) (8.10)
Inventories 0.08 0.10 0.10 0.10
Inventory Days 3.92 -- 4.21 4.68
Sundry debtors 0.35 0.47 0.21 0.31
Debtor days 17.20 -- 8.84 14.50
Other current assets 0.76 0.61 1.02 1.15
Sundry creditors (5) (4.70) (4.40) (4.20)
Creditor days 243 -- 184 196
Other current liabilities (2.80) (2.80) (4.40) (5.50)
Cash 0.21 0.06 0.11 0.08
Total assets (3.70) (2.70) (2.70) (1.10)
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Gross Sales 7.45 8.97 8.67 7.79 8.06
Excise Duty -- -- -- -- --
Net Sales 7.45 8.97 8.67 7.79 8.06
Other Operating Income -- -- -- -- --
Other Income 0.07 1.71 1.63 1.77 0.19
Total Income 7.52 10.70 10.30 9.56 8.25
Total Expenditure ** 6.25 7.65 8.09 7.68 8.10
PBIDT 1.27 3.03 2.21 1.87 0.15
Interest 0.59 0.66 0.84 1.06 0.52
PBDT 0.68 2.37 1.37 0.82 (0.40)
Depreciation 0.95 1.29 1.88 2.66 1.92
Minority Interest Before NP -- -- -- -- --
Tax -- 0.33 0.04 0.02 --
Deferred Tax (0.10) (0.10) (0.10) (0.10) (0.20)
Reported Profit After Tax (0.20) 0.82 (0.50) (1.70) (2.10)
Minority Interest After NP 0.03 0.01 (0.30) (0.40) (0.20)
Net Profit after Minority Interest (0.30) 0.81 (0.10) (1.40) (1.90)
Extra-ordinary Items -- 1.29 1.51 1.61 --
Adjusted Profit After Extra-ordinary item (0.30) (0.50) (1.70) (3) (1.90)
EPS (Unit Curr.) (0.30) 0.80 (0.30) (1.40) (2)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 9.96 9.96 9.96 9.96 9.46
Public Shareholding (Number) -- -- -- 3,779,420 3,779,420
Public Shareholding (%) -- -- -- 37.90 39.90
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- 6,202,220 5,702,220
Non Encumbered - % in Total Promoters Holding -- -- -- 100 100
Non Encumbered - % in Total Equity -- -- -- 62.10 60.10
PBIDTM(%) 17 33.80 25.50 24 1.86
PBDTM(%) 9.13 26.40 15.80 10.50 (4.60)
PATM(%) (3.10) 9.14 (5.20) (22) (26)